Project Grant HT94252410673
Award Date 6/30/24
Completion Date 6/29/27
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $766,965 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on June 30, 2024. The grant supports a 3-year research project to develop new methods for targeting kidney cancer tumors in order to improve immunotherapy outcomes. The research aims to identify tumor surface biomarkers that can be leveraged to enhance the effectiveness of cancer...
- The Defense Health Agency awarded a $1.1 million project grant to the University of Texas Southwestern Medical Center in Dallas, Texas, to support research under the Military Medical Research and Development program. The three-year award beginning in June 2023 will fund the development of a multifunctional immunotherapy nanoparticle to enable innate immunotherapy for kidney cancer. As the prime awardee, UT Southwestern will leverage its expertise in oncology and immunology to advance this...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,062,400 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to identify NEK5 as a hidden driver in kidney cancer. The grant has an award date of November 1, 2025 and an ultimate completion date of October 31, 2029. As a leading academic medical research institution, UT Southwestern will conduct advanced biomedical research to transform...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,083,136 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from August 15, 2023 through August 14, 2026 to leverage SCARB1 overexpression for the treatment of clear cell renal cell carcinoma (CCRCC) using low-density lipoprotein nanocarriers. UT Southwestern has extensive experience delivering...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $713,689 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, effective September 1, 2023, will support UT Southwestern's research to leverage biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. The grant provides funding for basic...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,297,895 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on identifying immunomodulatory targets of TAZ/SRF in sarcomatoid renal cell carcinoma progression. This 4-year research project, which commenced on September 1, 2025, aims to transform healthcare for military service members, veterans, and the broader public by...
- This $1,189,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to target stem-like CD8 T cells in immunotherapy against kidney cancer. The grant was awarded on September 1, 2023 to The University of Texas Southwestern Medical Center, an academic medical institution and component of the University of Texas System, to be completed by August 31, 2027. Through this funding, UT Southwestern will conduct research...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,107,000 project grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on tumor extravasation in zebrafish as a prognostic marker and therapeutic target for kidney cancer metastasis. The 3-year grant, which began on September 1, 2023 and runs through August 31, 2026, will support basic, applied, and advanced biomedical research with the...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $319,798 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) on April 15, 2024. The grant supports UT Southwestern's research to dissect unconventional mechanisms of action and resistance to rapalogs, a class of drugs, in renal cell carcinoma. The research aims to make significant advances in military medicine by improving...
- This federal Project Grant award of $319,800.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Texas Southwestern Medical Center, located in Dallas, TX. The award supports a research project titled "NOVEL HIF-2 REGULATORS AND THERAPEUTIC TARGETS FOR KIDNEY CANCER" with a performance period from November 1, 2025 to October 31, 2028. The project aims to conduct advanced biomedical research to...